Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

The prevalence of subclinical atherosclerosis and its risk factors in the newly diagnosed type 2 diabetes

Risk Factors for the Progress of Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetics with Multifactorial Intervention

Subclinical atherosclerosis evaluated by high resolution ultrasonography in patients with newly diagnosed type 2 diabetes mellitus un-dergoing intensive treatment

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Early-stage Atherosclerosis in Newly Diagnosed, Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

Effect of Multifactorial Intervention on Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetes

An Analysis of Risk Factors of Atherosclerosis in Patients with T2DM

THE CORONARY ANGIOGRAPHY FEATURES AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CORONARY HEART DISEASE COMPLICATED TYPE 2 DIABETES MELLITUS

Study of the Relationship Between Blood Glucose Fluctuation and Subclinical Atherosclerosis in Type 2 Diabetes Mellitus

Related Risk Factors between Subclinical Carotid Atherosclerosis and Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes Mellitus in China

Serum Metabolic Signatures of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus: a Preliminary Study

Adolescents And Young Adults With Newly Diagnosed Type 2 Diabetes Demonstrate Greater Carotid Intima-Media Thickness Than Those With Type 1 Diabetes

Analysis of Correlated Factors Influencing Macroangiopathy in Patients with New Onset Type 2 Diabetes Mellitus

Analysis of relative factors on the prevalence of macrovascular complications and their risk factors in newly-diagnosed patients with type 2 diabetes mellitus

Clinical Study of the Risk Factors in Type-2 Diabetes Patients with Vascular Occlusive Disease

Impact of Multifactorial Intervention on Subclinical Atherosclerosis in Patients with Newly-diagnosed Type 2 Diabetes

Analysis of influencing factors of carotid atherosclerosis plaque formation and stability in simple type 2 diabetic patients

Study of Carotic Intima-Media Thickness and Risk Factors in Patients with Type 2 Diabetes Mellitus

The Risk Factors of Carotid Intima-media Thickness in Newly Diagnosed Type 2 Diabetic Patients

Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis

Subclinical atherosclerosis associates with diabetic retinopathy incidence: a prospective study